Skip to main content
SpringerLink
Log in

First-line-Therapie beim lokal fortgeschrittenen oder metastasierten Urothelkarzinom

Randomisierte Phase-II-Studie zur Untersuchung der Kombinationen von Vinflunin mit Gemcitabin und Vinflunin mit Carboplatin in Cisplatin-ungeeigneten Patienten mit fortgeschrittenem oder metastasiertem Urothelkarzinom (JASINT-1 – AB 38/11) der AUO

First line therapy for local advanced or metastatic urothelial cell carcinoma

Randomized phase II study to investigate the combination of vinflunine with gemcitabine and vinflunine with carboplatin in patients unfit for cisplatin therapy with advanced or metastatic urothelial cell carcinoma (JASINT-1 – AB 38/11) of AUO

  • AUO
  • Published:
Der Urologe Aims and scope Submit manuscript

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Abb. 1

Literatur

  1. Stenzl A, Cowen NC, De Santis M et al (2010) Guideline on bladder cancer: muscle invasive and metastatic. Eur Assoc Urol 57:1013–1021

    Article  Google Scholar 

  2. Bellmunt J, Théodore C, Demkov T et al (2009) Phase III trial of vinflunine plus best supportive care compared with best supportive care alone after a platinum-containing regimen in patients with advanced transitional cell carcinoma of the urothelial tract. J Clin Oncol 27(27):4454–4461

    Article  PubMed  CAS  Google Scholar 

Download references

Interessenkonflikt

Keine Angaben.

Author information

Authors and Affiliations

  1. Geschäftsstelle der AUO, MeckEvidence, Seestraße 11, 17252, Schwarz, Deutschland

    H. Rexer

Authors
  1. H. Rexer
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to H. Rexer.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Rexer, H. First-line-Therapie beim lokal fortgeschrittenen oder metastasierten Urothelkarzinom. Urologe 50, 974–976 (2011). https://doi.org/10.1007/s00120-011-2667-7

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00120-011-2667-7

Search

Navigation